The Latest SPAC News and Rumors: September 28, 2021
by Marlena Haddad on 2021-09-28 at 11:25am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: SEC Gensler continues to express concern over SPACs; Revelation Biosciences receives approval to conduct Phase 2b viral challenge study


SEC’s Gensler Talks Up Crypto and SPAC Regulations

Securities and Exchange Commission Chairman Gary Gensler shed light on an array of hot-button topics during an interview on Monday, expressing his belief that “people will be hurt” if cryptocurrency markets are allowed operate beyond the remit of regulators, and voicing concerns that SPACs leave public market investors vulnerable.

Gensler expressed concern about the loose definitions around what SPACs can do with investors’ money. He noted how the structure incentivizes SPACs to find a merger deal “even if it’s not a particularly great merger”—potentially at the expense of the investors they are raising money from.
READ

Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99

Revelation Biosciences Inc., a clinical-stage life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, announced today it has received approval from the Federal Agency for Medicines and Health Products and the local Committee of Medical Ethics in Belgium to conduct a Phase 2b influenza viral challenge study.

The Phase 2b, randomized, double-blind, influenza viral challenge study is planned in healthy volunteers. This viral challenge investigation will evaluate the potential efficacy of a single- and repeat-dose of REVTx-99 prophylaxis versus placebo on viral load and clinical illness influenza symptoms.

On August 30th, Revelation Biosciences entered into a definitive agreement to combine with Petra Acquisition, Inc. (NASDAQ:PAIC).

READ

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-19 at 7:53am

At the SPAC of Dawn Happy Friday! SPACInsider has unveiled new presets on SPAC Performance accessible via the Data drop-down to easily sort for the highest and lowest performing active SPACs and de-SPACs. On the de-SPAC side, Vertiv (NYSE:VRT) continues to be well ahead of the pack, logging a 710% return by share price adjusted...

by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved